Science & Enterprise subscription

Follow us on Twitter

  • A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is co… https://t.co/wazhT6ZlRp
    about 13 hours ago
  • New post on Science and Enterprise: Genentech, Biotech Partner on Multiple Sclerosis https://t.co/0LVsKWN522 #Science #Business
    about 13 hours ago
  • New contributed post on Science and Enterprise: https://t.co/zBXBbIkYfN Careers Where Banter And Fun Come Into Their Own
    about 18 hours ago
  • A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer's disease wil… https://t.co/ayTyKvff5T
    about 1 day ago
  • New post on Science and Enterprise: Trial to Test App Alerting for Dementia-Linked Drugs https://t.co/N6RksAetEY #Science #Business
    about 1 day ago

Please share Science & Enterprise

Infographic – Security Top A.I. Application

Leading A.I. uses 2018

Click on image for full-size view (Statista.com)

6 Apr. 2019. As more businesses implement artificial intelligence or A.I., in their operations, boosting security is emerging as the leading way to use this technology. Our friends at Statista reported these findings yesterday in chart form, and it’s our infographic for this weekend.

Data for the chart come from a survey done last year for Consumer Technology Association, available for purchase from Statista, showing detection of security threats is the leading A.I. use, by more than 4 in 10 respondents worldwide. Nearly as many respondents (41%) say they use A.I. to help resolve customers’ technical questions, while about 1 in 3 each (34%) cite automating product management and tracking internal rules compliance as leading applications.

The data indicate companies are using various forms of A.I., such as voice recognition and natural language processing — technologies used in chatbots, for example — as well as machine learning. Most A.I. uses noted in Science & Enterprise are for scientific or medical decision making, such as in diagnostics, genomic analysis, and drug discovery, as cited in the links to recent stories below.

More from Science & Enterprise:

*     *     *

Comments are closed.